Login to Your Account

Isis, Alnylam Sign RNAi Deal; Goal To Make 'One-Stop Shop'

By Randall Osborne

Monday, March 15, 2004
Boasting a patent estate that the company's CEO said "covers everything that can be done" in antisense, Isis Pharmaceuticals Inc. entered a strategic alliance with Alnylam Pharmaceuticals Inc. that combines the pair's knowledge and expertise in the burgeoning field of RNAi. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription